REQUEST A DEMO
Total
USD $0.00
Search more companies

Welcure Drugs & Pharmaceuticals Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Welcure Drugs & Pharmaceuticals Ltd. Profile Updated: November 21, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Welcure Drugs & Pharmaceuticals Ltd. manufactures pharmaceuticals formulations in India. Welcure Drugs offers the products in the form of tablets, capsules, liquid orals, and herbals. The company was founded in 1992 and based in Delhi, India.

Legal Address
B- 9 &10, Laxmi Towers,, LSC, C Block, Saraswati Vihar
Delhi; Delhi; Postal Code: 110034

Contact Details: Purchase the Welcure Drugs & Pharmaceuticals Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Welcure Drugs & Pharmaceuticals Ltd. report to view the information.
Registered Capital:
Purchase the Welcure Drugs & Pharmaceuticals Ltd. report to view the information.
Financial Auditors:
Purchase the Welcure Drugs & Pharmaceuticals Ltd. report to view the information.
Incorporation Date:
1992
Key Executives
Purchase this report to view the information.
Co. Secretary & Compl. Officer
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Subsidiaries
AK Laboratories Pvt Ltd.
100%
Company Performance
Financial values in the chart are available after Welcure Drugs & Pharmaceuticals Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-75%
Net Profit (Loss) for the Period
-50%
Total equity
10.89%
Return on Equity (ROE)
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?